(4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate

C32H52O2 — CID 162853291

IUPAC(4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate
SMILESCC(=O)OC1CCC2(C)C3CCC4(C)C(=CCC5(C)CCC(C)C(C)C54)C3(C)CCC2C1(C)C
InChIInChI=1S/C32H52O2/c1-20-10-15-29(6)16-11-25-31(8)17-12-23-28(4,5)26(34-22(3)33)14-19-30(23,7)24(31)13-18-32(25,9)27(29)21(20)2/h11,20-21,23-24,26-27H,10,12-19H2,1-9H3
InChIKeyUXSZWTNSCFDGNM-UHFFFAOYSA-N
MW468.77 g/mol
LogP8.60
Rot. Bonds1

About (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate

(4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate (PubChem CID 162853291) has the molecular formula C32H52O2 and a molecular weight of 468.77 g/mol. Its IUPAC name is (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate.

Molecular Properties

Compound Name(4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate
PubChem CID162853291
Molecular FormulaC32H52O2
Molecular Weight468.77 g/mol
Exact Mass468.40
IUPAC Name(4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate
SMILESCC(=O)OC1CCC2(C)C3CCC4(C)C(=CCC5(C)CCC(C)C(C)C54)C3(C)CCC2C1(C)C
InChIInChI=1S/C32H52O2/c1-20-10-15-29(6)16-11-25-31(8)17-12-23-28(4,5)26(34-22(3)33)14-19-30(23,7)24(31)13-18-32(25,9)27(29)21(20)2/h11,20-21,23-24,26-27H,10,12-19H2,1-9H3
InChIKeyUXSZWTNSCFDGNM-UHFFFAOYSA-N
XLogP8.60
TPSA26.30 Ų
H-Bond Donors
H-Bond Acceptors2
Rotatable Bonds1
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500468.77
LogP ≤ 58.60
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate?
The IUPAC name of (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate (CID 162853291) is (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate.
What is the SMILES notation for (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate?
The canonical SMILES for (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate is CC(=O)OC1CCC2(C)C3CCC4(C)C(=CCC5(C)CCC(C)C(C)C54)C3(C)CCC2C1(C)C.
What is the InChIKey of (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate?
The InChIKey is UXSZWTNSCFDGNM-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H52O2/c1-20-10-15-29(6)16-11-25-31(8)17-12-23-28(4,5)26(34-22(3)33)14-19-30(23,7)24(31)13-18-32(25,9)27(29)21(20)2/h11,20-21,23-24,26-27H,10,12-19H2,1-9H3.
What are the key properties of (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate?
(4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate has a molecular weight of 468.77 g/mol, XLogP of 8.60, 1 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (4,4,6a,6a,8a,11,12,14b-octamethyl-2,3,4a,5,6,8,9,10,11,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl) acetate is sourced from PubChem (CID 162853291), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).